Avidity Biosciences
(NASDAQ:RNA)
$23.345
-0.205[-0.87%]
Last update: 11:57AM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Avidity Biosciences Stock (NASDAQ:RNA), Quotes and News Summary

Avidity Biosciences Stock (NASDAQ: RNA) stock price, news, charts, stock research, profile.

Open$23.550
Close-
Volume / Avg.305.350K / 1.172M
Day Range22.780 - 23.980
52 Wk Range4.825 - 27.660
Market Cap$1.861B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
50
Short Interest
12.66%
Days to Cover7.85

Recent News

Neuromuscular Focused-Avidity Biosciences Has 'Complete Package' - Analyst Predicts Stellar 142% Stock Surge
Cantor Fitzgerald initiates coverage on Avidity Biosciences highlighting a robust pipeline led by del-desiran, a promising treatment for Myotonic dystrophy type 1. With strong management, proven platform, and Phase 3 trials on the horizon, Avidity anticipates significant growth potential, targeting $1.3 in U.S. sales by 2031.
Vandana Singh
American Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Avi Kapoor
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its SEAL01 Bitcoin mining chip and amid overall strength in the price of Bitcoin.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
1
Jan
2
Feb
3
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Avidity Biosciences Inc
Sector
Health Care
Industry
Biotechnology
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleot...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RNA
TWST

FAQ

Q

How do I buy Avidity Biosciences (RNA) stock?

A

You can purchase shares of Avidity Biosciences (NASDAQ: RNA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Avidity Biosciences's (RNA) competitors?

A

Other companies in Avidity Biosciences’s space includes: Twist Bioscience (NASDAQ:TWST), Syndax Pharmaceuticals (NASDAQ:SNDX), Fusion Pharmaceuticals (NASDAQ:FUSN), PTC Therapeutics (NASDAQ:PTCT) and TG Therapeutics (NASDAQ:TGTX).

Q

What is the target price for Avidity Biosciences (RNA) stock?

A

The latest price target for Avidity Biosciences (NASDAQ: RNA) was reported by Needham on Thursday, April 11, 2024. The analyst firm set a price target for 35.00 expecting RNA to rise to within 12 months (a possible 48.62% upside). 16 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Avidity Biosciences (RNA)?

A

The stock price for Avidity Biosciences (NASDAQ: RNA) is $23.55 last updated April 17, 2024 at 4:00 PM EDT.

Q

Does Avidity Biosciences (RNA) pay a dividend?

A

There are no upcoming dividends for Avidity Biosciences.

Q

When is Avidity Biosciences (NASDAQ:RNA) reporting earnings?

A

Avidity Biosciences’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Q

Is Avidity Biosciences (RNA) going to split?

A

There is no upcoming split for Avidity Biosciences.

Q

What sector and industry does Avidity Biosciences (RNA) operate in?

A

Avidity Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch